Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
126.00    0.50 (0.40%)
Bid:
126.00
Ask:
129.00
Spread: 3.00 (2.381%)
Market Cap: £200.74m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Appointments to support forensic review

15 Nov 2016 07:00

RNS Number : 1422P
Redcentric PLC
15 November 2016
 

15 November 2016

 

Redcentric plc

("Redcentric" or the "Company")

 

Appointments to support forensic review

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, announces the following initial actions by the Board following the recent discovery of accounting misstatements.

 

To support the Board with its forensic review, both Deloitte LLP and Nabarro LLP have been appointed to carry out independent forensic investigations. 

 

Alongside these appointments, Redcentric has also appointed Julian Llewellyn as interim Chief Financial Officer. Julian is a very experienced Chief Financial Officer with over 25 years' experience in senior roles at companies such as Exertis, Balfour Beatty and Greenergy.

 

The search for a permanent Chief Financial Officer to join the Board is progressing well and the Company will make a subsequent announcement in due course.

 

Chris Cole, Chairman of Redcentric, commented:

 

"The past few days have obviously been challenging and difficult for everyone involved with Redcentric. Our priority now is to complete this review and report the findings to all our stakeholders together with our interim results." 

 

Enquiries:

 

Redcentric plc

Fraser Fisher, Chief Executive Officer

 

+44 (0)1423 850 000

Tulchan Group

James Macey White / Matt Low

 

+44 (0)20 7353 4200

Numis Securities Limited - Nomad & Joint Broker

Simon Willis / Oliver Hardy / Ben Stoop

 

+44 (0)20 7260 1000

finnCap Ltd - Joint Broker

Stuart Andrews / Rhys Williams

 

+44 (0)20 7220 0500

MXC Capital Markets LLP - Financial Adviser

Marc Young

+44 (0)20 7965 8149

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFUFMLFMSELF
Date   Source Headline
3rd Jun 20249:20 amRNSForm 8.5 (EPT/NON-RI)
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.